Exosomes for AD

NanoSomiX Inc. is developing a blood-based diagnostic that measures well-studied biomarkers of Alzheimer's disease as a cheaper and less invasive method to diagnose AD than spinal taps or brain imaging. The diagnostic also could be used to identify patients who are not yet symptomatic and to perform differential diagnoses.

NanoSomiX's diagnostic measures biomarkers in neural-derived exosomes, which can cross the blood-brain barrier. Exosomes are small vesicles shed by mammalian cells that contain non-degraded proteins and RNA specific to their cellular origin. ...